Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

7 treatments under study, led by Acetaminophen

Research Leaders

9 sponsors active, led by Indiana Hand to Shoulder Center

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed with results

Key Signals

2 with results67% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Phase 4 (1)

Trial Status

Completed2
Unknown2
Recruiting1
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (6)

Research Network

Common Treatments

  • Acetaminophen1
  • Joint Alloplasty1
  • Range Of Motion Tasks1
  • Synvisc Hylan Gf201
  • Strength Tasks1

Active Sponsors

  • Indiana Hand to Shoulder Center2
  • National Institutes of Health (NIH)1
  • Genzyme, a Sanofi Company1
  • Hospital for Special Surgery, New York1
  • Medical University of Warsaw1

Top Investigators

Related Conditions

  • Thumb Osteoarthritis2
  • Osteoarthritis1
  • Thumb1
  • Rhizarthrosis1
  • Trapeziometacarpal Osteoarthritis1

Activity Timeline